480 related articles for article (PubMed ID: 27215576)
1. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments.
Kassahun WT
World J Surg Oncol; 2016 May; 14(1):151. PubMed ID: 27215576
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
3. Management of fibrolamellar hepatocellular carcinoma.
Chaudhari VA; Khobragade K; Bhandare M; Shrikhande SV
Chin Clin Oncol; 2018 Oct; 7(5):51. PubMed ID: 30395718
[TBL] [Abstract][Full Text] [Related]
4. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.
Jernigan PL; Wima K; Hanseman DJ; Hoehn RS; Ahmad SA; Shah SA; Abbott DE
J Surg Oncol; 2015 Dec; 112(8):872-6. PubMed ID: 26603598
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
[TBL] [Abstract][Full Text] [Related]
6. Current management of hepatocellular carcinoma.
Zhou XD; Tang ZY; Yu YQ; Hou Z
Hepatogastroenterology; 1991 Dec; 38 Suppl 1():46-55. PubMed ID: 1668377
[TBL] [Abstract][Full Text] [Related]
7. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.
Pinna AD; Iwatsuki S; Lee RG; Todo S; Madariaga JR; Marsh JW; Casavilla A; Dvorchik I; Fung JJ; Starzl TE
Hepatology; 1997 Oct; 26(4):877-83. PubMed ID: 9328308
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients with fibrolamellar hepatocellular carcinoma.
Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP
Cancer; 2006 Mar; 106(6):1331-8. PubMed ID: 16475212
[TBL] [Abstract][Full Text] [Related]
9. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: current management and recent advances.
Lau WY; Lai EC
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
[TBL] [Abstract][Full Text] [Related]
11. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
[TBL] [Abstract][Full Text] [Related]
12. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of hepatocellular carcinoma: an update].
Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and selection of treatment modalities for hepatocellular carcinoma].
Okamura J; Monden M; Sakon M; Mori T; Kuroda C; Sakurai M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):203-9. PubMed ID: 3004362
[TBL] [Abstract][Full Text] [Related]
15. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
16. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
17. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
18. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis.
Glavas D; Bao QR; Scarpa M; Ruffolo C; Brown ZJ; Pawlik TM; Spolverato G
J Gastrointest Surg; 2023 Apr; 27(4):705-715. PubMed ID: 36797535
[TBL] [Abstract][Full Text] [Related]
19. Curative lung metastectomy and complete pathological response after neo-adjuvant GEMOX chemotherapy for relapse fibrolamellar hepatocellular carcinoma.
Eng JY; Soon SY; Winnie Ling HY
Med J Malaysia; 2018 Feb; 73(1):46-48. PubMed ID: 29531203
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective.
Mayo SC; Mavros MN; Nathan H; Cosgrove D; Herman JM; Kamel I; Anders RA; Pawlik TM
J Am Coll Surg; 2014 Feb; 218(2):196-205. PubMed ID: 24315886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
